Company Overview and News

20
Zacks.com highlights: athenahealth, Medifast, Commvault Systems, Molina Healthcare and Fortinet

2018-09-07 zacks
Chicago, IL – September 7, 2018 - Stocks in this week’s article include: athenahealth Inc (ATHN - Free Report) , Medifast (MED - Free Report) , Commvault Systems, Inc. (CVLT - Free Report) , Molina Healthcare, Inc. (MOH - Free Report) and Fortinet Inc. (FTNT - Free Report) .
ARLP CCR GLUU SHAK TPVZ LADR TPVY MOH MED GTIM GM FTNT JMP CVGI JMPB JMPC JMPD ALLY CVLT TPVG ATHN FG

3
Bet on These 5 Top Liquid Stocks for Stellar Returns

2018-09-07 investorplace
Investors may consider allocating their assets in stocks with a favorable liquidity position for big returns. Liquidity indicates a company’s capability of meeting debt obligations by converting assets into liquid cash and equivalents.
MOH MED CVLT ATHN FTNT

7
Bet on These 5 Top Liquid Stocks for Stellar Returns

2018-09-06 zacks
Investors may consider allocating their assets in stocks with a favorable liquidity position for big returns. Liquidity indicates a company’s capability of meeting debt obligations by converting assets into liquid cash and equivalents. Liquid stocks have always been in demand as these are believed to have the potential to boost portfolio returns. However, one should exercise caution before investing in such stocks.
MOH MED KHC CVLT ATHN FTNT

1
Tyler's CaseloadPRO Acquisition In Line With Growth Strategy

2018-09-05 zacks
TylerTechnologies (TYL - Free Report) has reportedly acquired Modesto, CA-based CaseloadPro, a provider of digital tools for managing probation cases, for an undisclosed amount.
TYL CVLT AZPN FTNT TYLE

3
Intuit (INTU) Hits 52-Week High: What's Driving the Stock?

2018-09-04 zacks
Share price of Intuit, Inc. (INTU - Free Report) rallied to a new 52-week high of $298.78, eventually closing a tad lower at $219.47 on Sep 3. The stock has rallied 39.1% year to date, substantially outperforming the 26.2% gain of the industry it belongs to. The stock price momentum can be attributed to consistent results. We note that the company beat the Zacks Consensus Estimate in the trailing four quarters, delivering an average positive surprise of 41.
INTU MSFT CVLT AZPN

10
Autodesk (ADSK) Q2 Earnings Top, Subscription Revenues Up Y/Y

2018-08-24 zacks
Autodesk (ADSK - Free Report) reported second-quarter fiscal 2019 non-GAAP earnings of 19 cents per share, which beat the Zacks Consensus Estimate by couple of cents. In the year-ago quarter, the company reported non-GAAP loss of 11 cents. Revenues of $611.7 million beat the consensus mark and increased nearly 22% year over year. The figure was better than management’s guidance of $595-$605 million.
NWL CVLT ADSK AZPN

101
The Zacks Analyst Blog Highlights: Southern, Constellation Brands, Vale, CME Group and Sempra Energy

2018-08-23 zacks - 4
Chicago, IL – August 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Southern Company (SO - Free Report) , Constellation Brands (STZ - Free Report) , Vale (VALE - Free Report) , CME Group (CME - Free Report) and Sempra Energy (SRE - Free Report) .
SOJA HD SO STZ.B TXN JELD STZ GAS CGC DLTR TWMJF 7018 CME SRE MOH WEED CVLT TAST

17
The Zacks Analyst Blog Highlights: Dollar Tree, BJ's Restaurants, Carrols Restaurant Group and TJX

2018-08-23 zacks
Chicago, IL – August 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Dollar Tree, Inc. (DLTR - Free Report) , BJ's Restaurants, Inc. (BJRI - Free Report) , Carrols Restaurant Group, Inc. (TAST - Free Report) and The TJX Companies, Inc.
SOJA HD SO STZ.B TXN JELD STZ DLTR TJX 7018 CME BJRI SRE MOH LULU CVLT TAST

13
The Zacks Analyst Blog Highlights: Target, Walmart, Amazon, Home Depot and Nordstrom

2018-08-23 zacks
Chicago, IL – August 23, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Target (TGT - Free Report) , Walmart (WMT - Free Report) , Amazon (AMZN - Free Report) , Home Depot (HD - Free Report) and Nordstrom (JWN - Free Report) .
SOJA HD SO STZ.B TXN JELD STZ WMT DLTR JWN TGT 7018 CME SRE MOH CVLT TAST

8
Zacks.com highlights: athenahealth, Commvault Systems, Molina Healthcare and Fortinet

2018-08-22 zacks
Chicago, IL – August 22, 2018 - Stocks in this week’s article include: athenahealth Inc. (ATHN - Free Report) , Commvault Systems, Inc. (CVLT - Free Report) , Molina Healthcare, Inc. (MOH - Free Report) and Fortinet Inc. (FTNT - Free Report) .
VGZ KGI PAG KGI.DB.A ENSG KGI.DB VGZ BGSF NDMWF MOH NAK CVLT LVS ATHN KL FTNT

3
4 Top Liquid Stocks for a Winning Portfolio

2018-08-21 zacks
Investors seeking strong returns may allocate their assets in stocks with favorable liquidity positions. Liquidity is an important yardstick that indicates a company’s capability to meet debt obligations by converting assets into cash. A company with a favorable liquidity position has the potential to provide higher returns as liquidity drives growth. However, one should exercise caution before investing in such stocks.
MOH MLNX CVLT ATHN FTNT

9
Brooks Automation (BRKS) Q3 Earnings Beat, Revenues Up Y/Y

2018-08-07 zacks
Brooks Automation (BRKS - Free Report) reported third-quarter fiscal 2018 adjusted earnings of 52 cents per share that beat the Zacks Consensus Estimate by a penny and surged 26.3% year over year. Net sales increased 22.9% year over year to $223.5 million, which comfortably surpassed the Zacks Consensus Estimate of $218 million. The year-over-year growth was driven by robust performance across both the segments.
AMT ENTG CVLT BRKS ADBE GTLS

9
The Zacks Analyst Blog Highlights: Goldman Sachs, JP Morgan Chase and Morgan Stanley

2018-08-07 zacks
Chicago, IL – August 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Goldman Sachs (GS - Free Report) , JP Morgan Chase (JPM - Free Report) and Morgan Stanley (MS - Free Report) .
GIII ADBE ECHO RCKY AMT MTN VNDA MLNX ARW CVLT MS ADM HUBG HUBOF GTLS

12
Zacks.com highlights: Steel Dynamics, Sprouts Farmers Market, Nucor, Big Lots and WellCare Health Plans

2018-08-07 zacks
Chicago, IL – August 7, 2018 - Stocks in this week’s article include: Steel Dynamics, Inc. (STLD - Free Report) , Sprouts Farmers Market, Inc. (SFM - Free Report) , Nucor Corp. (NUE - Free Report) , Big Lots, Inc. (BIG - Free Report) and WellCare Health Plans, Inc. (WCG - Free Report) .
STLD WCG BIG GIII NUE ADBE ECHO RCKY SFM AMT MTN VNDA MLNX ARW CVLT ADM HUBG HUBOF GTLS

9
The Zacks Analyst Blog Highlights: Harris, Huntington Ingalls Industries, Spirit Aerosystems, L3 Technologies, Raytheon and Leidos Holdings

2018-08-07 zacks
Chicago, IL – August 7, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Harris Corporation (HRS - Free Report) , Huntington Ingalls Industries, Inc. (HII - Free Report) , Spirit Aerosystems Inc. (SPR - Free Report) , L3 Technologies, Inc.
LMT GD LDOS GIII ADBE ECHO RCKY NOC HII AMT MTN VNDA MLNX ARW RTN CVLT HRS ADM HUBG HUBOF GTLS

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 204166102